NCT06554106 Neuromuscular Electrical Stimulation in Fibromyalgia
| NCT ID | NCT06554106 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Firat University |
| Condition | Fibromyalgia |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-08-20 |
| Primary Completion | 2024-10-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-08-20 with a primary completion date of 2024-10-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fibromyalgia syndrome (FMS) is associated with chronic widespread pain and at least eleven positive tender points out of 18 according to the American College of Rheumatology (ACR) 1990 criteria. Neuromuscular electrical stimulation (NMES) stimulates nerve fibers providing innervation in healthy muscle and muscle fibers in denervated muscle to produce contraction. All patients will be taught neck normal joint motion exercises, upper trapezius stretching exercise and posture exercises. Patients included in the study will be randomly distributed equally between the two groups. In addition to the study group, NMES will be applied to the upper trapezius muscle for 30 minutes 5 days a week for 4 weeks. Pain, disability and sleep quality of all patients will be evaluated.
Eligibility Criteria
Inclusion Criteria: * Patients who were aged between 18-65 years, * Patients who got diagnosed with Fibromyalgia Syndrome Exclusion Criteria: * Patients who had regular exercise habits, malignancy, pregnancy, incorporation * Patients who had changes of medical treatment in last 3 months * Patients who had dysfunction that can prevent physical activity
Frequently Asked Questions
Who can join the NCT06554106 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Fibromyalgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06554106 currently recruiting?
Yes, NCT06554106 is actively recruiting participants. Visit ClinicalTrials.gov or contact Firat University to inquire about joining.
Where is the NCT06554106 trial being conducted?
This trial is being conducted at Elâzığ, Turkey (Türkiye).
Who is sponsoring the NCT06554106 clinical trial?
NCT06554106 is sponsored by Firat University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.